The power of healthcare data gives rise to novel markers of cardiovascular disease and stroke in the earliest, preventable stages CHICAGO, Nov.11, 2018 — Developing novel approaches to understand cardiovascular health and pre-disease is the cornerstone strategy of One Brave Idea™, a research initiative led by Dr. Calum MacRae, vice chair for Scientific Innovation in the department of Medicine at Brigham ... Read More| Cleveland HeartLab, Inc.
– Cleveland HeartLab to be the base for Quest’s first national center of excellence in cardiometabolic disorders, with a focus on services that help patients and physicians nationwide identify hidden risks of heart disease – Relationship to establish a strategic collaboration to identify and offer diagnostic services from Cleveland Clinic’s innovations in inflammation and other areas of medicine SECAUCUS, N.J. and ... Read More| Cleveland HeartLab, Inc.
Download Press Release Innovative new test published in The New England Journal of Medicine detects levels of TMAO – which, when elevated, correlates with a two-fold increased risk of heart attack or stroke February 16, 2016, CLEVELAND: Cleveland HeartLab Inc., the premier cardiovascular disease management company, announced it has successfully developed, validated and launched a new clinical test for the assessment of ... Read More| Cleveland HeartLab, Inc.
As you know, the healthcare industry went through a major change with the implementation of ICD-10 codes on October 1, 2015. We want to ensure you that we are ICD-10 ready and are currently prepared to receive and process ICD-10 codes.| Cleveland HeartLab, Inc.
New Study Shows Cleveland HeartLab Inflammation Testing can Prevent Thousands of Heart Attacks and Strokes, Averting $187 Mil. in Healthcare Costs for CVD| Cleveland HeartLab, Inc.
Link to PRWeb Press Release Guelph, Ontario, Canada (February 23, 2015) Nutrasource Diagnostics Inc. (NDI) is pleased to announce its recent collaboration with Cleveland HeartLab (CHL) for the development of the OmegaCheck™ diagnostic blood test for the quantification of omega fatty acids. As a global leader in launching proprietary tests to more accurately assess cardiovascular disease risk, CHL developed and ... Read More| Cleveland HeartLab, Inc.
Link to PRWeb Press Release World-class, accredited continuing medical education (CME) now available as one-stop source for information on the identification and prevention of metabolic and cardiovascular disease CLEVELAND, March 9, 2015 – Cleveland HeartLab (CHL), the premier cardiovascular management company, announces the launch of its new CME Web Portal, Continuing Education from Cleveland HeartLab. The website (www.chlcme.com ) will ... Read More| Cleveland HeartLab, Inc.
The International Conference on Nutrition in Medicine will be held in Washington, D.C. , July 31st and August 1st, 2015. CHL is pleased to be an educational sponsor for the International Conference on Nutrition in Medicine, where Dr. Marc Penn will be speaking on “Laboratory tests: Which Ones Do I Need and Not Need?” Come join us and make sure ... Read More| Cleveland HeartLab, Inc.
Dear Colleagues, Upon completion of our 5th Annual symposium, “Where Inflammation Meets Lipids”, I believe it is an opportune time for a comment regarding our thoughts on the ACC/AHA National Cholesterol Guidelines. At this symposium we had a lively and detailed discussion/debate on the new guidelines and we are grateful to all that participated. We at Cleveland HeartLab support the ... Read More| Cleveland HeartLab, Inc.
